Earnings History Data for Elevation Oncology, Inc. (ELEV) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Elevation Oncology, Inc.
Elevation Oncology Inc. is a clinical stage biopharmaceutical company. It focused on the development of precision medicines for patients with genomically defined cancers. Elevation Oncology Inc. is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | PM | ELEV | Elevation Oncology | 31.00 | -0.22 | -0.20 | 0.00 | Elevation Oncology GAAP EPS of -$0.22 misses by $0.02 [11/6/2024 10:41 AM] |
0.5469 | -0.01 (-2.34%) |
0.57 | 0.01 (2.50%) |
0.36 - 5.83 | 753,270 | 730,000 | 34,071 | ||
| 06-08-2024 | PM | ELEV | Elevation Oncology | 129.00 | -0.18 | -0.23 | 0.00 | Elevation Oncology GAAP EPS of -$0.18 [8/6/2024 9:00 AM] |
0.7804 | -1.35 (-63.36%) |
1.03 | -1.10 (-51.64%) |
0.36 - 5.83 | 13,848,810 | 620,000 | 1,693,762 | ||
| 02-05-2024 | PM | ELEV | Elevation Oncology | 194.00 | -0.23 | -0.21 | 0.00 | Elevation Oncology GAAP EPS of -$0.23 [5/2/2024 8:07 AM] |
3.86 | -0.14 (-3.50%) |
3.73 | -0.27 (-6.75%) |
0.36 - 5.89 | 1,872,678 | 1,020,000 | 6,349 | ||
| 06-03-2024 | PM | ELEV | Elevation Oncology | 204.00 | -0.19 | -0.21 | 0.00 | Elevation Oncology GAAP EPS of -$0.19 [3/6/2024 10:00 AM] |
4.70 | 0.03 (0.54%) |
4.76 | 0.09 (1.93%) |
0.36 - 5.89 | 1,764,801 | 1,410,000 | 7,447 | ||
| 15-05-2023 | PM | ELEV | Elevation Oncology | 92.00 | -0.50 | -0.51 | 0.00 | Elevation Oncology GAAP EPS of -$0.72 [5/15/2023 9:48 AM] |
3.68 | -0.10 (-2.65%) |
0.0 | 0.0 (0.00%) |
0.72 - 4.61 | 61,072 | 170,000 | 0 | ||
| 03-11-2022 | PM | ELEV | Elevation Oncology | 26.00 | -1.67 | -1.12 | 0.00 | Elevation Oncology GAAP EPS of -$1.67 misses by $0.37 [11/3/2022 9:22 AM] |
1.09 | -0.07 (-6.03%) |
1.13 | -0.03 (-2.59%) |
0.98 - 8.99 | 30,708 | 30,000 | 2,941 | ||
| 04-08-2022 | PM | 7:30 AM ET (Aug 4) |
ELEV | Elevation Oncology | 26.00 | -0.86 | -0.80 | 0.00 | Elevation Oncology GAAP EPS of -$0.86 misses by $0.07 [8/4/2022 8:24 AM] |
1.27 | 0.11 (9.48%) |
3.92 | -0.40 (-9.26%) |
1.12 - 13.39 | 172,685 | 120,000 | 51,552 | |
| 05-05-2022 | PM | ELEV | Elevation Oncology | 69.00 | -0.74 | -0.51 | 0.00 | Elevation Oncology GAAP EPS of -$0.74 misses by $0.21 [5/5/2022 9:01 AM] |
3.67 | 0.62 (20.33%) |
0.0 | 0.0 (0.00%) |
2.27 - 16.22 | 95,740 | 50,000 | 0 | ||
| 03-03-2022 | PM | 7:30 AM ET (Mar 3) |
ELEV | Elevation Oncology | 77.00 | -0.41 | -0.59 | 0.00 | Elevation Oncology GAAP EPS of -$0.41 beats by $0.18 [3/3/2022 8:39 AM] |
3.30 | 0.04 (1.23%) |
0.0 | 0.0 (0.00%) |
3.19 - 16.22 | 1,560 | 40,000 | 0 | |
| 12-11-2021 | PM | ELEV | Elevation Oncology, Inc. | 191.38 | -0.53 | -0.35 | 0.00 | Elevation Oncology EPS misses by $0.15 [11/12/2021 8:58 AM] |
7.82 | -0.45 (-5.50%) |
8.25 | -0.02 (-0.24%) |
7.38 - 16.22 | 8,312 | 10,000 | 100 | ||